Primary Research · 2011
N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action
Dean O, Giorlando F, Berk M · Journal of Psychiatry and Neuroscience, 2011
Key finding
Reviews evidence for NAC as an adjunctive psychiatric treatment, with strongest data in trichotillomania, OCD, addictive behaviors, and as a glutathione precursor for oxidative stress reduction.
About the supplement
NAC (N-Acetyl Cysteine)
Dose · mechanism · evidence grade · safety →
Read the paper
Open on PubMedhttps://pubmed.ncbi.nlm.nih.gov/21118657/
About this page
Formulate maintains a registry of clinical studies cited across its guides and evidence grades. This page links the study metadata to the content that cites it — one canonical entry per landmark study.
The full citation chain is public so readers can verify claims without hunting through individual guide pages. Browse all cited studies →
Note: Study summaries on this page are editorial interpretations of the research. Always consult the primary source before drawing clinical conclusions.